More information about 1NKEMIA I

InKemia has as objective to generate knowledge of high technological value for the chemical, pharmaceutical, biotechnological, cosmetic, nutraceutical and related industries. This knowledge or know-how is transformed into a pipeline of products, processes, services and technological platforms that are highly specialized, integrated and protected by patents. Based on this, a group of business strategies are developed: 1 - Generation of a pipeline that covers final products and technological processes that are derived from the group’s own R&D, so that they can be patented, sold, and transferred to the industry. 2 - Co-development of R&D of high technological value with companies related to the sector, this way sharing the risks and benefits. 3 - Use of the developed technology by selling closed projects of highly specialized services under the mode “contract research” and “technology service”. 4 - The use, manufacturing and commercialization of products through spin-outs based on our own technology and that make sense to us as an independent company. The objective of this strategy is to have grater control over the know-how generated during the commercialization process. These spin-outs are open to the participation of specialized investors and independent managers. 5 - Creation of new companies as a result of third-party agreements or collaborations with technological entrepreneurs of related fields. 6 - Development of complementary services for the companies, clients and the general market, such